Vitrolife AB (publ)
SSE:VITR.ST
187.4 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,512 | 3,234 | 1,680.804 | 1,245.572 | 1,480.132 | 1,151.348 | 1,046.217 | 856.106 | 722.37 | 510.512 | 452.738 | 362.02 | 356.115 | 297.565 | 274.626 | 225.141 | 188.939 | 171.264 | 120.12 | 103.855 | 96.256 | 103.283 |
Cost of Revenue
| 1,774 | 1,454 | 634.714 | 477.905 | 541.48 | 390.224 | 364.508 | 294.805 | 237.55 | 161.394 | 152.183 | 123.72 | 117.842 | 91.41 | 81.741 | 68.891 | 59.274 | 54.744 | 37.193 | 29.481 | 34.617 | 53.921 |
Gross Profit
| 1,738 | 1,780 | 1,046.09 | 767.667 | 938.652 | 761.124 | 681.709 | 561.301 | 484.82 | 349.118 | 300.555 | 238.3 | 238.273 | 206.155 | 192.885 | 156.25 | 129.665 | 116.52 | 82.927 | 74.374 | 61.639 | 49.362 |
Gross Profit Ratio
| 0.495 | 0.55 | 0.622 | 0.616 | 0.634 | 0.661 | 0.652 | 0.656 | 0.671 | 0.684 | 0.664 | 0.658 | 0.669 | 0.693 | 0.702 | 0.694 | 0.686 | 0.68 | 0.69 | 0.716 | 0.64 | 0.478 |
Reseach & Development Expenses
| 122 | 143 | 114.45 | 91.759 | 99.515 | 88.457 | 69.116 | 61.59 | 55.737 | 41.925 | 58.874 | 41.204 | 47.176 | 43.144 | 38.574 | 30.669 | 26.889 | 24.183 | 15.819 | 12.228 | 13.964 | 30.642 |
General & Administrative Expenses
| 433 | 400 | 259.456 | 114.424 | 119.382 | 99.27 | 99.334 | 94.146 | 80.467 | 59.96 | 55.891 | 45.17 | 50.576 | 82.224 | 38.831 | 35.449 | 28.775 | 24.339 | 20.525 | 20.59 | 25.11 | 33.658 |
Selling & Marketing Expenses
| 684 | 602 | 244.285 | 196.927 | 231.582 | 184.537 | 170.279 | 155.686 | 139.86 | 112.098 | 108.11 | 102.028 | 98.36 | 87.552 | 80.275 | 64.869 | 53.105 | 47.241 | 38.855 | 28.216 | 24.307 | 28.306 |
SG&A
| 883 | 1,002 | 503.741 | 311.351 | 350.964 | 283.807 | 269.613 | 249.832 | 220.327 | 172.058 | 164.001 | 147.198 | 148.936 | 169.776 | 119.106 | 100.318 | 81.88 | 71.58 | 59.38 | 48.806 | 49.417 | 61.964 |
Other Expenses
| -5 | 12 | 1.488 | -11.25 | -0.013 | -0.212 | -0.356 | 1.666 | 0.357 | 0.923 | 2.462 | 0.929 | 0.997 | -39.825 | 4.797 | -1.862 | -0.138 | 0.73 | -4.326 | 0.298 | -43.617 | -165.659 |
Operating Expenses
| 1,005 | 1,145 | 619.679 | 391.86 | 450.466 | 372.052 | 338.373 | 313.088 | 276.299 | 213.275 | 221.737 | 188.18 | 197.109 | 173.095 | 162.477 | 129.125 | 108.631 | 96.493 | 70.873 | 61.332 | 19.764 | -73.053 |
Operating Income
| 733 | 654 | 435.379 | 370.015 | 487.946 | 393.915 | 340.856 | 248.841 | 226.135 | 143.346 | 80.398 | 49.725 | 40.917 | 33.06 | 30.408 | 27.125 | 21.034 | 20.027 | 12.054 | 13.042 | 41.875 | 122.415 |
Operating Income Ratio
| 0.209 | 0.202 | 0.259 | 0.297 | 0.33 | 0.342 | 0.326 | 0.291 | 0.313 | 0.281 | 0.178 | 0.137 | 0.115 | 0.111 | 0.111 | 0.12 | 0.111 | 0.117 | 0.1 | 0.126 | 0.435 | 1.185 |
Total Other Income Expenses Net
| -4,445 | -117 | 24.59 | -3.824 | 4.748 | 9.511 | -2.421 | 0.717 | 18.319 | 11.081 | 0.97 | -0.382 | 3.938 | 8.193 | 0.179 | 0.089 | -2.628 | -4.988 | 3.204 | -1.318 | -2.369 | -5.589 |
Income Before Tax
| -3,712 | 537 | 459.969 | 366.191 | 492.694 | 398.583 | 340.915 | 248.93 | 226.84 | 146.924 | 79.788 | 49.738 | 45.102 | 41.253 | 30.587 | 27.214 | 18.406 | 15.039 | 15.258 | 11.724 | 39.506 | 116.826 |
Income Before Tax Ratio
| -1.057 | 0.166 | 0.274 | 0.294 | 0.333 | 0.346 | 0.326 | 0.291 | 0.314 | 0.288 | 0.176 | 0.137 | 0.127 | 0.139 | 0.111 | 0.121 | 0.097 | 0.088 | 0.127 | 0.113 | 0.41 | 1.131 |
Income Tax Expense
| 139 | 143 | 116.405 | 78.325 | 108.855 | 87.886 | 76.313 | 57.718 | 43.479 | 37.456 | 23.088 | 23.191 | 14.458 | 12.071 | -3.782 | -2.986 | -17.651 | -0.16 | -0.399 | -0.212 | -5.178 | -0.636 |
Net Income
| -3,851 | 394 | 341 | 286.845 | 382.785 | 309.697 | 263.64 | 190.368 | 182.845 | 109.109 | 56.274 | 333.772 | 30.36 | 29.182 | 34.114 | 29.995 | 36.057 | 15.199 | 14.859 | 11.936 | 44.684 | 116.503 |
Net Income Ratio
| -1.097 | 0.122 | 0.203 | 0.23 | 0.259 | 0.269 | 0.252 | 0.222 | 0.253 | 0.214 | 0.124 | 0.922 | 0.085 | 0.098 | 0.124 | 0.133 | 0.191 | 0.089 | 0.124 | 0.115 | 0.464 | 1.128 |
EPS
| -28.44 | 2.91 | 2.97 | 2.64 | 3.53 | 2.85 | 2.43 | 1.75 | 1.68 | 1.09 | 0.57 | 3.41 | 0.31 | 0.3 | 0.35 | 0.3 | 0.36 | 0.15 | 0.16 | 0.14 | 0.49 | 1.27 |
EPS Diluted
| -28.44 | 2.91 | 2.97 | 2.64 | 3.53 | 2.85 | 2.43 | 1.75 | 1.68 | 1.09 | 0.57 | 3.41 | 0.31 | 0.3 | 0.35 | 0.3 | 0.36 | 0.15 | 0.16 | 0.14 | 0.49 | 1.27 |
EBITDA
| 1,158 | 995 | 577.042 | 443.852 | 594.978 | 482.589 | 407.581 | 304.198 | 262.902 | 168.418 | 123.761 | 77.401 | 41.411 | 50.834 | 30.408 | 27.125 | 20.678 | 16.594 | 22.165 | 13.042 | 44.271 | 124.694 |
EBITDA Ratio
| 0.33 | 0.308 | 0.343 | 0.356 | 0.402 | 0.419 | 0.39 | 0.355 | 0.364 | 0.33 | 0.273 | 0.214 | 0.116 | 0.171 | 0.111 | 0.12 | 0.109 | 0.097 | 0.185 | 0.126 | 0.46 | 1.207 |